Abstract

A novel series of coumarin–pyrazoline hybrids 3a–f, 4a–c and 5a–c have been synthesized and tested for their antiproliferative activity against the breast cancer cell line MCF-7.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call